These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 355181)

  • 21. A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.
    Chengappa KN; Goldstein JM; Greenwood M; John V; Levine J
    Clin Ther; 2003 Feb; 25(2):530-41. PubMed ID: 12749512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia.
    Conley RR; Kelly DL; Nelson MW; Richardson CM; Feldman S; Benham R; Steiner P; Yu Y; Khan I; McMullen R; Gale E; Mackowick M; Love RC
    Clin Neuropharmacol; 2005; 28(4):163-8. PubMed ID: 16062094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
    Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
    Chan HY; Lin AS; Chen KP; Cheng JS; Chen YY; Tsai CJ
    J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High vs standard dosage fluphenazine HCL in acute schizophrenia.
    Donlon PT; Meadow A; Tupin JP; Wahba M
    J Clin Psychiatry; 1978 Nov; 39(11):800-4. PubMed ID: 363702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suspension therapy in acute schizophrenia. Clinical and neuroendocrine/biochemical effects of abrupt discontinuation of neuroleptic medication.
    Kuhs H; Folkerts H
    Neuropsychobiology; 1995; 31(3):135-45. PubMed ID: 7609862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Amineptine versus imipramine. Double-blind controlled study].
    Oules J; Boscredon J
    Presse Med; 1983 Oct; 12(36):2243-6. PubMed ID: 6226963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protrptyline in the treatment of chronic schizophrenic patients.
    Arbitman R; Yurtcu A; Lehmann HE; Sterlin C; Ban TA; Jarrold L
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):131-5. PubMed ID: 4985491
    [No Abstract]   [Full Text] [Related]  

  • 30. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Pinto R; Bannerjee A; Ghosh N
    Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pimozide versus Haloperidol in acute schizophrenia. A double blind controlled study.
    Haas S; Beckmann H
    Pharmacopsychiatria; 1982 Mar; 15(2):70-4. PubMed ID: 7043498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of supidimide in schizophrenic inpatients undergoing neuroleptic maintenance therapy with haloperidol.
    Rapisarda V; Aguglia E; Poma A
    Eur J Clin Pharmacol; 1982; 22(3):217-23. PubMed ID: 7049709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equipercentile linking of the BPRS and the PANSS.
    Leucht S; Rothe P; Davis JM; Engel RR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulpiride and perphenazine in schizophrenia. A double-blind clinical trial.
    Lepola U; Koskinen T; Rimón R; Salo H; Gordin A
    Acta Psychiatr Scand; 1989 Jul; 80(1):92-6. PubMed ID: 2669445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.
    Takahashi H; Kamata M; Yoshida K; Ishigooka J; Higuchi H
    J Clin Psychiatry; 2006 Oct; 67(10):1577-82. PubMed ID: 17107250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Butaclamol in acute schizophrenia].
    Gallart Capdevila JM
    Arch Neurobiol (Madr); 1975; 38(6):545-86. PubMed ID: 1225244
    [No Abstract]   [Full Text] [Related]  

  • 37. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
    J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: combined results of the North American and international trials.
    Davis JM; Chen N
    J Clin Psychiatry; 2001 Oct; 62(10):757-71. PubMed ID: 11816864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity in chronic schizophrenic patients: comparison of pimozide with fluphenazine in a double blind trial.
    Sims AC; Burnside IG
    Psychol Med; 1975 May; 5(2):161-4. PubMed ID: 1099598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.